IGF1 and major depressive disorder: These findings provide the latest evidence on serum IGF-1 levels in patients with first-episode and drug-naïve MDD compared with healthy controls, and supports existing meta-analyses demonstrating increased IGF-1 levels in MDD patients (4, 28–30).